COMMUNIQUÉS West-GlobeNewswire

Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates
05/08/2025
Second -quarter 2025 Rezdiffra™ (resmetirom) net sales of $212.8 million As of June 30, 2025 , more than 23,000 patients on Rezdiffra Received new U.S. Rezdiffra patent providing protection to Feb. 4, 2045 Announced [...]
Foghorn Therapeutics Provides Second Quarter 2025 Financial and Corporate Update
05/08/2025
FHD-909 (LY4050784) Phase 1 dose escalation trial in SMARCA4 (BRG1) mutated cancers, with non-small cell lung cancer (NSCLC) as the primary target population, is enrolling well and remains on track Preclinical [...]
Sagimet Biosciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
05/08/2025
SAN MATEO, Calif., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Envision Pharma Group appoints Tom Langan as Chief Executive Officer
05/08/2025
Envision Pharma Group appoints Tom Langan as Chief Executive Officer Leading industry executive with 30 years’ of experience providing technology-enabled solutions to life sciences companies Fairfield, Connecticut, USA [...]
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
05/08/2025
AC Immune Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Three active immunotherapies for precision prevention of neurodegeneration progressing through Phase 2 clinical development ACI- [...]
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
05/08/2025
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency (EMA) orphan drug [...]
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance
05/08/2025
Kuros Biosciences launches MagnetOs MIS Delivery System by completing first cases, and continues global expansion with incremental Brazil clearance Schlieren (Zürich), Switzerland, August 5, 2025 – Kuros Biosciences (“ [...]
Nicox annonce l’initiation par son partenaire Kowa d’un essai clinique de Phase 3 pour NCX 470 au Japon
05/08/2025
Communiqué de presse Nicox annonce l’initiation par son partenaire Kowa d’un essai clinique de Phase 3 pour NCX 470 au Japon Kowa, le partenaire exclusif de Nicox au Japon, a initié un essai clinique de sécurité de [...]
Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan
05/08/2025
Press Release Nicox’s Partner Kowa Initiates NCX 470 Phase 3 Clinical Trial in Japan Exclusive Japanese partner Kowa has initiated a Phase 3 safety clinical trial of NCX 470 for the treatment of ocular hypertension in [...]
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
05/08/2025
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025 UK Clinical Trial Application (CTA) approval shortly follows U.S. IND clearance and granting of European Medicine Agency (EMA) orphan drug [...]
Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market
05/08/2025
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents at Angiotech Pharma Appointment adds world-class capabilities to Tensive as the [...]
CancerVax Successfully Disguises Cancer Cells and Tricks Immune Cells into Attacking Them
05/08/2025
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune cells into attacking the malignant cells LEHI, Utah, Aug. 05, 2025 (GLOBE NEWSWIRE [...]
Where to Buy Modafinil in the UK: Complete Guide for Smart Buyers in 2025
05/08/2025
This guide provides tips about buying modafinil in the UK, from its uses and modafinil legal status to finding the best place to order and get modafinil with fast shipping. It also spotlights the best modafinil vendor [...]
Praxis Precision Medicines to Participate in Upcoming Fireside Chat
05/08/2025
BOSTON, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines , Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Avis aux médias: L’Hôpital Shriners pour enfants Canada invite les médias à son tournoi de golf annuel
04/08/2025
MONTRÉAL, 04 août 2025 (GLOBE NEWSWIRE) -- Quoi : L’Hôpital Shriners pour enfants Canada convie les représentants des médias à une occasion spéciale de photos et d’entrevues dans le cadre de son tournoi de golf annuel, [...]
Media advisory: Shriners Hospitals for Children Canada Invites Media to its Annual Golf Tournament
04/08/2025
MONTREAL, Aug. 04, 2025 (GLOBE NEWSWIRE) -- What: Shriners Hospitals for Children Canada invites members of the media to attend a special photo and interview opportunity during its Annual Golf Tournament at Summerlea [...]
Dunham House to Partner with CrossMed Healthcare Staffing
04/08/2025
OMAHA, Neb., Aug. 04, 2025 (GLOBE NEWSWIRE) -- Dunham House, a first-of-its-kind, transformational initiative for combat-wounded veterans in need of long-term residential-centered care for their wounds, will partner [...]
Syndax Reports Second Quarter 2025 Financial Results and Provides Business Update
04/08/2025
– $28.6 million of Revuforj ® (revumenib) net revenue, representing 43% growth over 1Q25 – – $36.2 million of Niktimvo™ (axatilimab-csfr) net revenue reported by Incyte in first full quarter of launch; $9.4 million in [...]
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia
04/08/2025
First regulatory approval for PYRUKYND in thalassemia, evaluated under SFDA’s Breakthrough Medicines Program Agios partnered with NewBridge Pharmaceuticals, a regional specialty company focused on the Middle East and [...]

Pages